Biomarkers in Lung Cancer

Catherine R. Sears, Peter J. Mazzone

Research output: Contribution to journalReview article


Biomarkers that focus on lung cancer risk assessment, detection, prognosis, diagnosis, and personalized treatment are in various stages of development. This article provides an overview of lung cancer biomarker development, focusing on clinical utility and highlighting 2 unmet clinical needs: selection of high-risk patients for lung cancer screening and differentiation of early lung cancer from benign pulmonary nodules. The authors highlight biomarkers under development and those lung cancer screening and nodule management biomarkers post-clinical validation. Finally, trends in lung cancer biomarker development that may improve accuracy and accelerate implementation in practice are discussed.

Original languageEnglish (US)
JournalClinics in Chest Medicine
StateAccepted/In press - Jan 1 2020


  • Clinical utility
  • Lung cancer screening
  • Lung nodules
  • Next-generation sequencing
  • Radiomics
  • Trial design

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Fingerprint Dive into the research topics of 'Biomarkers in Lung Cancer'. Together they form a unique fingerprint.

Cite this